Dr. Tal Zaks’ Drive To Improve Patients’ Lives

Exsilio Therapeutics’ CEO Tal Zaks was Moderna’s CMO during the creation of the COVID-19 vaccine, but he has also served patients as a physician, scientist, investor, and biotech builder.
An excerpt from "Biotech Story Time With Tal Zaks, M.D. (Part 1)" - check out the full video at www.bioprocess...
---
#businessofbiotech #biopharma #biotech
Subscribe to the podcast:
Apple - podcasts.apple...
Spotify - open.spotify.c...
TH-cam - • The Business Of Biotec...